Actium Group
Overview
Actium Group is a growth equity investment firm that partners with life science and technology companies in North America, Europe, and Asia, providing multi-stage capital and managerial support.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GenrAb, Inc. | Apr 2025 | Seed | Lead |
| Signify Bio | Jun 2025 | Seed | Lead |
| Kesmalea Therapeutics | Nov 2026 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Actium Group based?
Actium Group is headquartered in Dallas, Texas, United States.
When was Actium Group founded?
Actium Group was founded in 2009.
How many portfolio companies does Actium Group have?
Actium Group has 4 portfolio companies in Caplight's dataset.
What are some companies in Actium Group's portfolio?
Portfolio companies visible on Caplight include GenrAb, Inc., Signify Bio, Kesmalea Therapeutics.
What was Actium Group's most recent investment shown here?
Actium Group's most recent investment in this portfolio sample was in Kesmalea Therapeutics in 2026.
What sectors does Actium Group focus on?
Actium Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Actium Group focus on?
Actium Group typically invests at the Early stage.